Please login to create your UC TechAlerts.
Request a new password for
No technologies match these criteria. Schedule UC TechAlerts to receive an email when technologies are published that match this search. Click on the Save Search link above
Find technologies available for licensing from UCLA.
Diagnostic Markers to Distinguish Between Squamous Cell Carcinoma and Pseudoepitheliomatous Hyperplasia
UCLA scientists have developed a novel diagnostic kit to reliably distinguish squamous cell carcinoma (SCC) from pseudoepitheliomatous hyperplasia (PEH). This fast diagnostic test can replace the non-quantitative and subjective diagnostic methods currently used in hospitals.
Fully Human Antibodies and Fragments Recognizing c-Met
UCLA researchers in the Department of Molecular and Medical Pharmacology have developed several novel recognition sequences against the human oncogene c-MET. These unique sequences are the basic building blocks used to make intact human antibodies and antibody fragments that can be conjugated to various payloads endowing them with great therapeutic and diagnostic potential in vitro and in vivo.
Diagnostic, Prognostic and Therapeutic Uses of Non-Coding RNAs in Leukemia
The Rao group at UCLA has developed a method of using lincRNA expression levels as a diagnostic and prognostic tool for B acute lymphoblastic leukemia. Furthermore, regulation of certain leukemia-associated lincRNA may hold therapeutic potential.
Homogenous Entropy-Driven Biomolecular Assay (HEBA)
Professors in the UCLA Department of Bioengineering have developed a novel short oligonucleotide assay to fluorescently detect biomolecules.
Wide-Field Imaging Of Birefringent Crystals In Synovial Fluid Using Lens-Free Polarized Microscopy For Crystal Arthropathy Diagnosis
UCLA researchers in the Department of Electrical Engineering have developed a new diagnostic tool for arthropathic diseases, such as gout.
Artificial Human Mutation Controls for Clinical Diagnostic Genetic and Proficiency Testing
Brief description not available
Novel Monoclonal Antibodies against Neospora Caninum
UCLA researchers have developed a large number of highly specific monoclonal antibodies against the intracellular parasite Neospora caninum that can be used for diagnostic or research purposes.
Intelligent Nanomedicine Integrating Diagnosis and Therapy
PIAS Proteins and Its Monoclonal Antibody as Diagnostics and Therapeutics for Immunological Disorders and Cancer
Soluble and Cell-associated Hemojuvelins as a Therapy and Diagnostic for Iron Metabolism Diseases
Non-invasive Optometric Medical Diagnostic Device
UCLA researchers in the Department of Mechanical and Aerospace Engineering have developed a non-invasive, fast, low-cost optometric device that monitors changes in skin proteins to pre-screen diseases such as diabetes and skin cancer.
Diagnostic Test for Mutations in the AT Gene
Trauma-released Proteins and Breakdown Products for Diagnosing Injury Severity, Pharmacokinetic Monitoring and Outcome Prediction in Neurotrauma Patients
UCLA researchers have identified a novel panel of neurotrauma biomarkers to diagnose traumatic brain injury (TBI), spinal cord injury (SCI) and concussions.
An Amplified and Overexpressed Gene in Colorectal Cancers
NMR Probe for the Detection of Microstructures
UCLA researchers in the Department of Chemistry and Biochemistry have developed an NMR probe with superior sensitivity for in vivo spectroscopy and detection of ultra small samples.
Multi-Modal Depth-Resolved Tissue Status And Contact Pressure Monitor
Researchers in the UCLA Bioengineering Department have developed a device to detect changes in blood oxygenation of neonate intestines to allow for diagnosis of necrotizing enterocolitis.
Expression and Purification of ATM Protein using Vaccinia Virus
Noninvasive Screening for Gestational Diabetes
Dr. Brian Koos in the Department of Obstetrics and Gynecology at UCLA has developed a noninvasive and accurate screening technology to identify gestational diabetes during early pregnancy.
Method of Using Carbonic Anhydrase IX as a Molecular Marker for Predicting Survival in Advanced Renal Clear Cell Carcinoma
Method for Screening Delta Opioid Receptor Modulators
Dr. Christopher Evans, Director of the Brain Research Institute at UCLA, and colleagues have developed a screening methodology for identifying modulators of the delta opioid recepto
Enhanced Fluorescence Readout And Reduced Inhibition For Nucleic Acid Amplification Tests
UCLA researchers in the Department of Bioengineering have developed an enhanced fluorescent detection method for nucleic acid amplification tests.
Predictive Markers for Dasatinib to Treat Solid Tumors
Investigators at the UCLA Geffen School of Medicine have identified potential markers to predict the response of breast cancer patients to dasatinib, an oral multi-kinase SRC/ABL inhibitor. There is potential to use these markers in the clinical development of dasatinib and other SRC kinase inhibitors that treat solid tumors.
Process For Sorting Dispersed Colloidal Structures
Researchers from the Chemistry and Biochemistry department at UCLA have developed method of separating and/or sorting specific target structures from other non-target structures in a complex mixture using custom-made target-specific colloidal particles.
Blood Markers for Lung Cancer Predisposition
UCLA researchers have identified blood markers for predisposition to lung cancer.
Mutations in Ataxia-telangiectasia Gene
Gateway to Innovation, Research and Entrepreneurship